Cat. #160388
INA-6-CD63-EGFP cell line
Cat. #: 160388
Sub-type: Continuous
Unit size: 1x10^6 cells / vial
Availability: 10-12 weeks
Organism: Human
Tissue: Blood
Disease: Cancer
£575.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Gaute Brede
Institute: Norwegian University of Science and Technology (NTNU)
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: INA-6-CD63-EGFP cell line
- Cancer: Blood cancer
- Cancers detailed: Myeloma
- Research fields: Cell biology
- Tool sub type: Continuous
- Parental cell: INA6
- Organism: Human
- Tissue: Blood
- Disease: Cancer
- Description: This human myeloma cell line expresses CD63-EGFP that labels extracellular vesicles including exosomes and microvesicles (EVs). The cell line is useful for the study of EV exchange between donor and acceptor cells and also for the study of tunnelling nanotubes (TnTs). The cell line is particularly useful for interaction-studies between myeloma and stroma-cells.
- Cellosaurus id: CVCL_5209
Target Details
- Target: INA6-CD63
Handling
- Format: Frozen
- Growth medium: Culture in RPMI-1640 with 5% heat inactivated fetal calf serum (FCS) added with 1 ng/ml IL-6 and 200 ??g/ml G418 (Geneticin) at 37?°C in a humidified atmosphere containing 5% CO2.
- Unit size: 1x10^6 cells / vial
- Shipping conditions: Dry ice
